Cellular and Humoral Response to the 3rd COVID-19 Vaccine Dose in Immunocompromised Children; a Multi-Division Prospective Cohort
Monday, April 25, 2022
1:15 PM – 1:30 PM US MT
Location: Convention Center: 709/711
CE: Enduring CME: 0.25
Publication Number: 3550.2
Heather Morgans, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Rangaraj Selvarangan, Children's Mercy Hospitals and Clinics, kansas city, MO, United States; Aliessa Barnes, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Julie Bass, Children’s Mercy Hospital, Kansas City, MO, United States; Todd Bradley, Children's Mercy Hospitals and Clinics, kansas city, MO, United States; Ashley Cooper, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Ryan Fischer, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Linda Flebbe-Rehwaldt, Eurofins-Viracor, Lees Summit, MO, United States; Steve Kleiboeker, Eurofins Viracor, Lees Summit, MO, United States; Brian R. Lee, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Kelsey E. Markus, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Stephen Morrison, Children's Mercy Hospitals and Clinics, Baldwin City, KS, United States; Angela L. Myers, Children's Mercy Kansas City, Kansas City, MO, United States; Doug Myers, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Erin Payne, Children's Mercy Hospital, Kansas City, MO, United States; Jennifer Schuster, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Sarah Standley, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; BRADLEY A. WARADY, CHILDREN'S MERCY KANSAS CITY, KANSAS CITY, MO, United States
Presenting Author(s)
HM
Heather Morgans, D.O.
Pediatric Nephrologist Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States
Participants should be aware of the following financial/non-financial relationships:
Heather Morgans, D.O.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rangaraj Selvarangan, BVSc, PhD: ● Baebies Inc (Ended In the Past 24 Months) (Products/Services: Consultant). ● Becton Dickinson (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● BioFire Diagnostics (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Bio-RAd Diagnostics (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Cepheid (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Diasorin (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● GSK (Currently Ongoing) (Products/Services: Advisory Committee). ● Luminex (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Merck (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Aliessa Barnes, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Julie Bass, DO: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Todd Bradley, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ashley Cooper, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ryan Fischer, MD: ● Albireo (Currently Ongoing) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Mirum (Currently Ongoing) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness).
Linda Flebbe-Rehwaldt, PH.D.: ● Eurofins-Viracor (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Steve Kleiboeker, PhD: ● Eurofins Viracor (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Brian R. Lee, PhD, MPH: ● Merck (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Pfizer (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Kelsey E. Markus, BS in Psychology: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Stephen Morrison, Bachelor of Science in Nursing: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Angela L. Myers, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Doug Myers, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Erin Payne, BSN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jennifer Schuster, MD: ● Merck (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Sarah Standley, Bachelor of Science in Nursing: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Bradley A. Warady, Medical Doctor: ● Amgen (Currently Ongoing) (Products/Services: Consultant). ● Bayer (Currently Ongoing) (Products/Services: Consultant). ● Lightline Medical (Currently Ongoing) (Products/Services: Consultant). ● Reata (Currently Ongoing) (Products/Services: Consultant).
